Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978; 42: 143 - 146.Lorell B, Alderman EL, Mason ~ Cardiac sarcoidosis: diag- nosis with endomyocardial biopsy and treatment with cortico- steroids. Am J Cardio11978; 42:143-46...
Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, Hosenpud JD (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11:367–369 CAS PubMed Google Scholar Yager JE, Hernandez AF, Steenbergen C, Persing...
After the combined therapy with steroids, digitalis and an angiotensin-1 receptor antagonist, mediastinal mass and Tei index were reduced and the ejection fraction moved to 56%. Dyspnoea was classified with Grade II according to the NYHA classification. Treatment of asymptomatic sarcoidosis is still ...
We report the case of a previously healthy 45-year-old white man in whom sustained ventricular tachycardia and severe myocardial dysfunction were the only signs of cardiac sarcoidosis. Diagnosis was confirmed by endomyocardial biopsy, and the patient responded well to treatment with amiodarone and pred...
Sarcoidosis is an unusual cause of heart disease that occurs as isolated organ involvement and as part of systemic disease. The first case of cardiac sarcoidosis (CS) was reported in 1929 by Bernstein et al.1 Publications in the subsequent 40 years consi
Sarcoidosis is an inflammatory multisystemic disease of unknown etiology characterized by the formation of noncaseating epithelioid cell granulomas. Cardiac sarcoidosis might be life-threatening and its diagnosis and treatment remain a challenge nowadays. The aim of this review is to provide an updated...
Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging Giant cell myocarditis, but not cardiac sarcoidosis, is known to cause fulminant myocarditis resulting in severe heart failure. However, giant cell myo...
Treatment strategies aim to mitigate the long-term effects of CS on the heart; however, there is a paucity of data for appropriate pharmacological regimens. Introduction Cardiac sarcoidosis (CS) is clinically manifested in approximately 5% of patients with systemic sarcoidosis...
Objective: Cardiac involvement in sarcoidosis can present in various ways, with atrioventricular (AV) block and ventricular arrhythmias being the most common signs. Because of initial non-specific findings, diagnosis can be a challenge. Very few data can support treatment decisions as cardiac ...
Abstract 12678: Steroids versus Steroid-Sparing Agents in Cardiac Sarcoidosis: A Retrospective Analysis of Clinical Outcomesdoi:10.1161/circ.146.suppl_1.12678Heart diseaseImmunosuppressive therapyInflammationOutcomesDrugsIntroduction:Equipoise remains on whether initial therapy for cardiac sarcoidosis (CS) should ...